Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2010

01-12-2010 | Original Paper

Challenges in Using Mobile Phones for Collection of Antiretroviral Therapy Adherence Data in a Resource-Limited Setting

Authors: Jessica E. Haberer, Julius Kiwanuka, Denis Nansera, Ira B. Wilson, David R. Bangsberg

Published in: AIDS and Behavior | Issue 6/2010

Login to get access

Abstract

Frequent antiretroviral therapy adherence monitoring could detect incomplete adherence before viral rebound develops and thus potentially prevent treatment failure. Mobile phone technologies make frequent, brief adherence interviews possible in resource-limited settings; however, feasibility and acceptability are unknown. Interactive voice response (IVR) and short message service (SMS) text messaging were used to collect adherence data from 19 caregivers of HIV-infected children in Uganda. IVR calls or SMS quantifying missed doses were sent in the local language once weekly for 3–4 weeks. Qualitative interviews were conducted to assess participant impressions of the technologies. Participant interest and participation rates were high; however, weekly completion rates for adherence queries were low (0–33%), most commonly due to misunderstanding of personal identification numbers. Despite near ubiquity of mobile phone technology in resource-limited settings, individual level collection of healthcare data presents challenges. Further research is needed for effective training and incentive methods.
Literature
1.
World Health Organization. Toward universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report 2009, WHO Press: Geneva.
2.
Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from adult AIDS clinical trials group protocol 370. Antivir Ther. 2002;7(3):185–93.PubMed
3.
Lima VD, Harrigan R, Bangsberg DR, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50(5):529–36.CrossRefPubMed
4.
Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.CrossRefPubMed
5.
Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445–8.CrossRefPubMed
6.
Parienti JJ, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.CrossRefPubMed
7.
8.
Beyond voice, in the economist. September 24, 2009.
9.
Schroder KE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV/AIDS Rep. 2009;6(4):210–6.CrossRefPubMed
10.
Schroder KE, Johnson CJ, Wiebe JS. Interactive voice response technology applied to sexual behavior self-reports: a comparison of three methods. AIDS Behav. 2007;11(2):313–23.CrossRefPubMed
11.
Corkrey R, Parkinson L. Interactive voice response: review of studies 1989–2000. Behav Res Methods Instrum Comput. 2002;34(3):342–53.PubMed
12.
Perrine MW, Mundt JC, Searles JS, Lester LS. Validation of daily self-reported alcohol consumption using interactive voice response (IVR) technology. J Stud Alcohol. 1995;56(5):487–90.PubMed
13.
Barta WD, Kiene SM, Tennen H, Abu-Hasaballah KS, Ferrer R. The idiographic study of inconsistent condom use behavior of persons living with HIV. AIDS Care. 2007;19(8):1058–64.CrossRefPubMed
14.
Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009;36(2):165–73.CrossRefPubMed
15.
16.
17.
Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2009;6(4):194–200.CrossRefPubMed
18.
Ybarra ML, Bull SS. Current trends in internet- and cell phone-based HIV prevention and intervention programs. Curr HIV/AIDS Rep. 2007;4(4):201–7.CrossRefPubMed
19.
Chang LW, Kagaayi J, Nakigozi G, et al. Responding to the human resource crisis: peer health workers, mobile phones, and HIV care in Rakai, Uganda. AIDS Patient Care STDS. 2008;22(3):173–4.CrossRefPubMed
20.
Curioso WH, Kurth AE. Access, use and perceptions regarding internet, cell phones and PDAs as a means for health promotion for people living with HIV in Peru. BMC Med Inform Decis Mak. 2007;7:24.CrossRefPubMed
21.
Abayomi A, Goodridge W, Asika O. Wireless networks for surveillance, data capture and data management in the human immunodeficiency virus epidemic care and treatment programmes. Afr J Med Med Sci. 2006;35(Suppl):149–52.PubMed
22.
Puccio JA, Belzer M, Olson J, et al. The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study. AIDS Patient Care STDS. 2006;20(6):438–44.CrossRefPubMed
23.
24.
25.
26.
Lester RT, Mills EJ, Kariri A, et al. The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials. 2009;10:87.CrossRefPubMed
27.
Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320(7227):114–6.CrossRefPubMed
28.
Ehiri JE, Anyanwu EC, Donath E, Kanu I, Jolly PE. AIDS-related stigma in sub-Saharan Africa: its contexts and potential intervention strategies. AIDS Public Policy J. 2005;20(1–2):25–39.PubMed
29.
Gaudine A, Glen L, Thuan TT, Dung do V. Perspectives of HIV-related stigma in a community in Vietnam: a qualitative study. Int J Nurs Stud. 2010;47(1):38–48.CrossRefPubMed
30.
Intille SS. Ubiquitous computing technology for just-in-time motivation of behavior change. Stud Health Technol Inform. 2004;107(Pt 2):1434–7.PubMed
31.
Patrick K, Griswold WG, Raab F, Intille SS. Health and the mobile phone. Am J Prev Med. 2008;35(2):177–81.CrossRefPubMed
32.
VanDevanter N, Parikh NS, Cohall RM, et al. Factors influencing participation in weekly support groups among women completing an HIV/STD intervention program. Women Health. 1999;30(1):15–34.PubMed
33.
Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med. 2000;15(12):841–7.CrossRefPubMed
34.
Nachega JB, Leisegang R, Bishai D, et al. Association of antiretroviral therapy adherence and health care costs. Ann Intern Med. 2010;152(1):18–25.PubMed
35.
Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.CrossRefPubMed
36.
Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–91.CrossRefPubMed
37.
Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Glob Health. 2006;2:9.CrossRef
Metadata
Title
Challenges in Using Mobile Phones for Collection of Antiretroviral Therapy Adherence Data in a Resource-Limited Setting
Authors
Jessica E. Haberer
Julius Kiwanuka
Denis Nansera
Ira B. Wilson
David R. Bangsberg
Publication date
01-12-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9720-1

Other articles of this Issue 6/2010

AIDS and Behavior 6/2010 Go to the issue

REview Paper

Sampling Methods Used in Developed Countries for Behavioural Surveillance Among Men who have Sex with Men

Review Paper

Alcohol Use and Sexual Risk Behaviors and Outcomes in China: A Literature Review

Original Paper

Real-Time Adherence Monitoring for HIV Antiretroviral Therapy

Original Paper

Social Grants, Welfare, and the Incentive to Trade-Off Health for Income among Individuals on HAART in South Africa

OriginalPaper

Substance Use in HIV-Infected Women During Pregnancy: Self-Report Versus Meconium Analysis

Original Paper

Efficacy of HIV Prevention Interventions in Latin American and Caribbean Nations, 1995–2008: A Meta-Analysis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits